Phenotypic screen for oxygen consumption rate identifies an anti-cancer naphthoquinone that induces mitochondrial oxidative stress
dc.contributor.author | Byrne, Frances L. | en |
dc.contributor.author | Olzomer, Ellen M. | en |
dc.contributor.author | Marriott, Gabriella R. | en |
dc.contributor.author | Quek, Lake-Ee | en |
dc.contributor.author | Katen, Alice | en |
dc.contributor.author | Su, Jacky | en |
dc.contributor.author | Nelson, Marin E. | en |
dc.contributor.author | Hart-Smith, Gene | en |
dc.contributor.author | Larance, Mark | en |
dc.contributor.author | Sebesfi, Veronica F. | en |
dc.contributor.author | Cuff, Jeff | en |
dc.contributor.author | Martyn, Gabriella E. | en |
dc.contributor.author | Childress, Elizabeth | en |
dc.contributor.author | Alexopoulos, Stephanie J. | en |
dc.contributor.author | Poon, Ivan K. | en |
dc.contributor.author | Faux, Maree C. | en |
dc.contributor.author | Burgess, Antony W. | en |
dc.contributor.author | Reid, Glen | en |
dc.contributor.author | McCarroll, Joshua A. | en |
dc.contributor.author | Santos, Webster L. | en |
dc.contributor.author | Quinlan, Kate G. R. | en |
dc.contributor.author | Turner, Nigel | en |
dc.contributor.author | Fazakerley, Daniel J. | en |
dc.contributor.author | Kumar, Naresh | en |
dc.contributor.author | Hoehn, Kyle L. | en |
dc.contributor.department | Chemistry | en |
dc.contributor.department | Center for Drug Discovery | en |
dc.date.accessioned | 2020-01-14T18:37:55Z | en |
dc.date.available | 2020-01-14T18:37:55Z | en |
dc.date.issued | 2020-01 | en |
dc.description.abstract | A hallmark of cancer cells is their ability to reprogram nutrient metabolism. Thus, disruption to this phenotype is a potential avenue for anti-cancer therapy. Herein we used a phenotypic chemical library screening approach to identify molecules that disrupted nutrient metabolism (by increasing cellular oxygen consumption rate) and were toxic to cancer cells. From this screen we discovered a 1,4-Naphthoquinone (referred to as BH10) that is toxic to a broad range of cancer cell types. BH10 has improved cancer-selective toxicity compared to doxorubicin, 17-AAG, vitamin K3, and other known anti-cancer quinones. BH10 increases glucose oxidation via both mitochondrial and pentose phosphate pathways, decreases glycolysis, lowers GSH:GSSG and NAPDH/NAPD(+) ratios exclusively in cancer cells, and induces necrosis. BH10 targets mitochondrial redox defence as evidenced by increased mitochondrial peroxiredoxin 3 oxidation and decreased mitochondrial aconitase activity, without changes in markers of cytosolic or nuclear damage. Over-expression of mitochondria-targeted catalase protects cells from BH10-mediated toxicity, while the thioredoxin reductase inhibitor auranofin synergistically enhances BH10-induced peroxiredoxin 3 oxidation and cytotoxicity. Overall, BH10 represents a 1,4-Naphthoquinone with an improved cancer-selective cytotoxicity profile via its mitochondrial specificity. | en |
dc.description.notes | FLB was supported by a postdoctoral fellowship from the Hope Funds for Cancer Research (HFCR-14-06-04) and is currently supported by a Cancer Institute NSW ECF (2018/ECF003). Financial support was provided in part by a UNSW faculty collaboration grant to KLH and NK. JM is supported by a Cancer Institute NSW CDF. GEM was supported by an Australian Postgraduate Award. KGRQ is supported by a UNSW Sydney Scientia Fellowship. | en |
dc.description.sponsorship | Hope Funds for Cancer Research [HFCR-14-06-04]; Cancer Institute NSW ECF [2018/ECF003]; UNSW; Cancer Institute NSW CDF; Australian Postgraduate AwardAustralian Government; UNSW Sydney | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | https://doi.org/10.1016/j.redox.2019.101374 | en |
dc.identifier.issn | 2213-2317 | en |
dc.identifier.other | UNSP 101374 | en |
dc.identifier.pmid | 31743887 | en |
dc.identifier.uri | http://hdl.handle.net/10919/96431 | en |
dc.identifier.volume | 28 | en |
dc.language.iso | en | en |
dc.rights | Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en |
dc.subject | Cancer metabolism | en |
dc.subject | Quinone | en |
dc.subject | Peroxiredoxin | en |
dc.subject | Mitochondria | en |
dc.title | Phenotypic screen for oxygen consumption rate identifies an anti-cancer naphthoquinone that induces mitochondrial oxidative stress | en |
dc.title.serial | Redox Biology | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
dc.type.dcmitype | StillImage | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 1-s2.0-S2213231719308845-main.pdf
- Size:
- 2.19 MB
- Format:
- Adobe Portable Document Format
- Description: